Craig Steinback

Title: Innovations in Cardiorespiratory Measurement by Craig Steinback

Introduction

Craig Steinback is an innovative inventor based in Edmonton, Canada. He has made significant contributions to the field of medical technology, particularly in the measurement of cardiorespiratory responses. His work focuses on understanding sympathetic nervous system activity and blood vessel autoregulation.

Latest Patents

Steinback holds a patent for a "System and method for measuring cardiorespiratory response." This invention involves systems and methods for measuring sympathetic nervous system activity or blood vessel autoregulation corrected for sympathetic activity. The process includes imaging the choroid in the human eye and measuring the vascular perfusion density (VPD) within it. VPD serves as a direct measurement related to sympathetic nervous system activity. By comparing pre-stimuli and post-stimuli VPD measurements, the effects of various stimuli on sympathetic nervous system activity can be assessed. Additionally, altered sympathetic nervous system activity can be detected by comparing a subject's VPD measurements to baseline measurements from healthy individuals.

Career Highlights

Throughout his career, Craig Steinback has focused on advancing medical technologies that enhance our understanding of physiological responses. His innovative approach to measuring VPD has opened new avenues for research and clinical applications in understanding sympathetic nervous system dynamics.

Collaborations

Steinback has collaborated with notable colleagues, including Richard A Wilson and Nicholas Jendzjowsky. These partnerships have contributed to the development and refinement of his patented technologies.

Conclusion

Craig Steinback's contributions to the field of cardiorespiratory measurement exemplify the impact of innovative thinking in medical technology. His patent on measuring sympathetic nervous system activity through VPD is a testament to his dedication to advancing healthcare solutions.